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Abstract 
Purpose: There is evidence that novel psychoactive substances (NPS) are commonly used by 
people with severe mental illness. The aim of the study was to undertake a scoping survey to 
explore inpatient mental health workers' perceptions of NPS use by consumers. 
Design/methodology: A cross-sectional online survey of mental health professionals. 
Participants were opportunistically recruited through social media and professional networks.   
Findings: A total of 98 participants (of 175 who started the survey) were included in the 
analysis.  All reported that some patients had used NPS prior to admission.  Over 90% of 
participants reported observing at least one adverse event relating to NPS use in the previous 
month. The majority of participants reported that patients had used NPS during their 
inpatient admission. Three quarters were not clear if their workplace had a policy about NPS. 
Most wanted access to specific NPS information and training. Participants reported that they 
lacked the necessary knowledge and skills to manage NPS use in the patients they worked 
with.       
Research Limitations/Implications: Whilst we are cautious about the generalizability (due to 
methodological limitations), our findings provide useful insight into the perceptions of 
inpatient staff regarding the extent and impact of NPS use including concerns regarding 
impact on mental and physical health, as well as ease of availability and a need for specific 
training and guidance. 
Practical Implications: Mental health professionals require access to reliable and up to date 
information on changing trends in substance use. Local policies need to include guidance on 
the safe clinical management of substance use and ensure that NPS information is included. 
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Background 
It is estimated that around a third of people with serious mental health problems also have 
substance use issues (Menezes et al., 1996, Regier et al., 1990). Co-occurring substance use 
and mental health have been associated with adverse consequences including suicide and 
self-harm, homicides, homelessness, offending, poor treatment outcomes and recidivism, 
poor physical health and social problems (McCrone et al., 2000, Mueser et al., 2000, Wright et 
al., 2000).   
Substance use is a common co-morbidity in people admitted to inpatient mental health. In a 
study of substance use in inner city mental health units, Phillips and Johnson (2003) found 
that a significant proportion of inpatients had substance use problems prior to admission, 
and many were still using substances during their stay.  Substance use is an identified risk 
factor for violence on inpatient mental health wards (Iozzino et al., 2015).  
All hospital settings are required by law (for example, in UK, the Misuse of Drugs Act 1971 
section 8)1 to prevent illicit substance use from occurring on the premises and must have 
local policies and procedures in place in order to minimise this.  Substance use has also been 
identified as a cause of management problems due to the impact of intoxication on a 
person’s mental state, interactions with prescribed medications and the acute physiological 
consequences of toxicity (Department of Health 2006; Brotto and Lee, 2007). Craving and 
withdrawal may also exacerbate anxiety and agitation. In addition to this, intoxication and/or 
                                                             
1 http://www.legislation.gov.uk/ukpga/1971/38/section/8 
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withdrawal can lead to physical harm such as head injuries; overdose; aspiration of vomit, 
and respiratory depression (Independent Expert Working Group, 2017; Department of 
Health, 2006).  
Despite the fact that substance use is a common issue in mental health inpatient facilities, 
clinicians often lack skills and confidence to effectively manage and intervene. The reason for 
this may be due to a lack of training and support related to this aspect of health. In the UK 
and Australia, surveys of mental health inpatient staff relating to working with substance use 
have consistently highlighted that despite the frequency of encountering substance use, the 
workforce is under-equipped to deliver effective care (Happell et al., 2002, Howard and 
Holmshaw, 2010, Hughes et al., 2012, Ryrie and McGowan, 1998, Siegfried et al., 1999).  
In the last few years, illicit substance use patterns are changing in the general population.  
There is an emerging use of a range of novel psychoactive substances (NPS) (also known as 
“legal highs”, “designer drugs” “research chemicals”).  NPS can be classified by chemical 
groupings including phenethylamines, amphetamines, synthetic cathinones, piperazines, 
pipradrols/piperidines, aminoindanes, benzofurans, tryptamines and synthetic cannabinoids. 
These are synthetic substances used to obtain psychoactive effects similar to illicit drugs.  
There are a myriad of substances and according to the latest report from the ECMDDA there 
are currently over 450 drugs registered in the EU monitoring system (ECMDDA 2015).  
In terms of safety, there have been alerts concerning both non-fatal overdoses and deaths 
following NPS use.  For example, a recent study (Norman and Lee, 2017) suggests that the 
London Ambulance Service has responded to increasing numbers of NPS related emergency 
calls over the last 4 years and there were over 1300 Emergency Department presentations 
associated with NPS in London alone during 2014.  However, it is often problematic to 
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identify all potential NPS emergency presentations due to a lack of information in clinical 
notes, and consequently there is limited reliable epidemiological evidence relating to levels 
and type of NPS use.  
In the UK (up to 2016), NPS sale and use were not regulated by law and were sold openly on 
the internet and in high street “head shops”.  However, due to increasing concerns about the 
safety and impact of NPS use, the UK government made all “psychoactive substances” illegal 
in 2016 (excluding tobacco, and caffeine). Other countries in Europe also have introduced 
legislation to include psychoactive substances not previously covered by their drug laws2).  
Since the change in UK laws, there has been a sharp decline in the numbers of people buying 
NPS on the high street but an increase in those buying the substances online (Norman and 
Lee, 2017).    
There is some evidence that NPS use is having a disproportionate impact on vulnerable 
populations that include people who are homeless, those in prison, and the mentally ill 
(European Monitoring Centre For Drugs and Drug Addiction, 2017).  A recent review of the 
literature concerning impact of NPS on those with mental illness (Gray et al., 2016) reported 
that very little research has been undertaken in this area. However, several case studies were 
retrieved and these focused on describing life-threatening and adverse events as a result of 
NPS use by people using mental health treatment.  These included both physical and mental 
health crises that required emergency medical/psychiatric treatment.   
Anecdotally, mental health nurses are reporting an increase in NPS use in patients presenting 
to psychiatric inpatient units. However, little is known about the nature extent and impact of 
                                                             
2 http://www.emcdda.europa.eu/publications/joint-publications/eurojust/nps-
legislation-and-prosecution 
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NPS on those who use mental health services.  The aim of this initial exploratory study was to 
identify the perceptions and concerns of staff that currently work in mental health inpatient 
facilities.  Specifically, the survey focused on 3 areas: the staff observation of NPS use; the 
impact of use; and their training and support needs.  The findings of the survey will be used 
to inform more robust research plans regarding NPS use in mental health services.   
Method 
Design: The study design was a cross-sectional online survey using an opportunistic 
convenience sample. 
Participants 
Participants were included if they were a professional working in inpatient mental health 
settings based in any region of the world.  As we were sharing the link to the survey via social 
media, we did not want to exclude any participants or any regions of the world.  In addition, 
to protect anonymity we did not collect information on the names of the services or the 
locations where participants worked.   
Recruitment 
We recruited participants by posting on three social media platforms (FacebookTM, LinkedinTM 
and TwitterTM). A number of established email groups (e.g. Mental Health Academics UK, 
Australian College of Mental Health Nursing (ACMHN) were also contacted. The post or email 
contained brief details of the study and a link to the survey. Once the link was clicked, the 
first page provided more detailed information about the survey, why it was being done and 
how to the data would be used (participant information sheet). Participants provided consent 
by indicating this on the survey. They were then required to confirm that they were a mental 
health professional working in an inpatient service (i.e. they met the study inclusion criteria). 
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Respondents who did not agree to take part and/or were not currently working in inpatient 
services were thanked for their help and directed away from the survey.   
 
Questionnaire 
A draft survey was created in Qualtrics based on a review of the literature and discussions 
with between the study authors. This initial version was pilot tested and some minor edits 
were made (regarding the wording of questions, not content).  The final questionnaire had 10 
items.   A copy is available from the lead author on request.  
Questions included:  
 Role, type of service and region of the world 
 An estimate of the percentage of patients admitted to their ward who had used NPS 
in the past month  
 Whether they perceived that people use NPS during an admission 
 Whether they perceived they have adequate information on NPS 
 Whether they were aware that NPS featured in their local organisation drug policy 
 Their perceptions of the impact of NPS use on the patients on their ward  
 Availability and use of interventions to support patients who use NPS.   
In addition to the main survey questions, there were two free-response questions inviting 
participants to comment about their concerns about NPS use, and their training and support 
needs.  
 
Ethical Approval 
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The University of Huddersfield School of Human and Health Sciences Research Ethics Panel 
reviewed the project, and approval to conduct the study was issued on the 19th January 
2016.    
Sample size 
We considered this an exploratory study in order to scope the perceptions and concerns of 
inpatient staff, in order to inform the development of future research plans and therefore 
aimed to recruit a convenience sample of a minimum of 100 participants.   
Statistical methods 
Analysis of quantitative data was conducted in SPSS Version 20 (IBM, 2011). Where 
appropriate, the chi-square test of independence was utilised to examine the relationship 
between job role (registered mental health nurse vs. ‘other’ practitioners) and questions 
surrounding NPS. Cramer’s V was also calculated to measure effect size; values of .2 indicate 
a small effect, .5 a medium effect and .8 a large effect (Cohen, 1988).  The text from the free-
response questions were cut and pasted into a word document, and read by one of the 
researchers.  The text was then placed under emerging themes. This was a simple process as 
the data was limited to one word or brief phrases.   
 
Results 
Participants  
Of the 175 practitioners that started the survey and gave consent, 118 (67.43%) confirmed 
that they work in an inpatient facility providing care for persons with mental health 
problems. Twenty participants were excluded from the analysis because the questionnaire 
was not completed. This gave us a final sample of 98 participants (83.05%).  
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Most practitioners were working in Europe (n=77; 79%) but there were also a small number 
from Australasia (n=9; 9%), the Middle East (n=6; 6%), South East Asia (n=4; 4%), North 
America (n=1; 1%) and Africa (n=1; 1%). Most participants working in Europe (n=31; 40%) and 
all other geographical regions (n=12; 57%) reported practising in general adult inpatient 
mental health services, as opposed to other types of inpatient units.  
 
In terms of professional role, most of the respondents identified as nurses.   There were 68 
(58%) registered mental health nurses; 10 (8%) registered nurses working in mental health; 
10 (8%) healthcare assistants or support workers; 7 (6%) psychologists; 9 (8%) were 
psychiatrists, and 14 (12%) identified as “other allied health professional).  
 
Perceptions of Extent of NPS Use 
We asked participants to estimate the proportion of patients that had used NPS in the month 
prior to admission to their facility.  Using the 80 numeric responses to this question, the 
mean estimate was 28% (S.D.=23.8), the mode was 15% (15 responses), and median was 20.  
There was a regional difference in this estimate with some European participants reporting 
use as high as 70-80% of admissions who they perceived had used NPS in the last month (n=7 
respondents). The proportion of service users estimated to have used NPS was re-
categorised into ≤49% and ≥50% in order to compute the chi square test of independence. 
The association between region and estimated NPS use was significant and small, X2 (1, N = 
82) = 5.54, p = .019, Cramer’s V = .26. Post hoc tests revealed that in ‘other’ regions fewer 
practitioners than expected believed that ≥50% of patients had used NPS prior to admission.  
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Observed Consequences of NPS Use 
Participants were asked to indicate whether they had observed any of the following 
consequences of NPS use: deterioration of mental state; aggression; deterioration of physical 
health; needed emergency treatment 
As displayed in table 1, deterioration of mental state was the most frequently observed 
consequence, reported by 88 (85.71%) of all practitioners. This was closely followed by 
aggression, which was observed by 77 (78.57%) of all practitioners. Although fewer 
participants reported observing deterioration of physical health (n = 65; 66.33%) or the need 
for emergency treatment (n = 61; 62.24%), these were still reported to be common 
occurrences.  
 
Practitioners in Europe were more likely to report having observed deterioration of mental 
and physical health (91.21% and 71.43% respectively) than practitioners in ‘other’ regions 
(61.90% and 47.62% respectively). Significant and small associations were found between 
region and mental health deterioration, X2 (1, N = 98) = 12.37, p < 0.001, Cramer’s V = .36, 
and physical health deterioration, X2 (1, N = 98) = 4.18, p = .041, Cramer’s V = .21. Post hoc 
tests revealed that in ‘other’ regions more participants than expected indicated that they had 
not observed deterioration of mental or physical health.  
 
The difference for needing emergency treatment was more pronounced; 71.43% of 
practitioners in Europe reported that they had observed this compared to 28.57% of those in 
‘other regions. The association between region and emergency treatment was significant and 
small, X2 (1, N = 98) = 12.90, p < 0.001, Cramer’s V = .36. In ‘other’ regions, fewer participants 
 10 
than expected reported that they had witnessed patients needing emergency treatment as a 
result of NPS use. 
 
Table 1: Number (%) of practitioners reporting they had observed consequences of NPS use  
Consequence of 
NPS use 
Europe 
N = 77 
‘Other’ 
regions 
N = 21 
Registered 
MH nurses 
N = 56 
‘Other’ 
practitioners 
N = 42 
Total sample 
N = 98 
Deterioration of 
mental state 
71 (92.21) 13 (61.90) 51 (91.07) 33 (78.57) 84 (85.71) 
Aggression 62 (80.52) 15 (71.43) 46 (82.14) 31 (73.81) 77 (78.57) 
Deterioration of 
physical health 
55 (71.43) 10 (47.62) 40 (71.43) 25 (59.52) 65 (66.33) 
Needed 
emergency 
treatment 
55 (71.43) 6 (28.57) 35 (62.50) 26 (61.90) 61 (62.24) 
 
Perceptions of Access to NPS During Admission  
Most (89%) of the European participants indicated that it was their perception that service 
users could access and use NPS during admission, compared to half (50%) of those in ‘other’ 
regions. This association was statistically significant and had a small effect size, X2 (1, N = 87) 
= 13.05, p < .001, Cramer’s V = .39. In ‘other’ regions fewer participants than expected 
thought that service users could access NPS. The proportion of registered mental health 
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nurses (82.35%) and ‘other’ practitioners (80.25%) that thought service users could access 
NPS did not differ.  
 
When asked whether NPS featured in their local substance use policy, only a quarter of the 
sample indicated yes.   
 
 
 
 
Table 2: Number (%) of practitioners indicating that NPS featured in substance misuse policy 
NPS features in 
policy 
Total sample 
N = 96 
Yes  25 (26.04) 
No 43 (44.79) 
Don’t know 28 (29.17) 
 
Almost a third of participants were uncertain whether NPS featured in their local substance 
misuse policy at their facility (see table 2).  
 
Interventions for NPS 
Participants were presented with a list of nine possible interventions (see Table 7) and were 
asked to indicate which were used in response to NPS within their setting. Participants were 
free to tick as many as they required.  Although many practitioners indicated that a range of 
responses were utilised (74.49% ticked ≥4 interventions), there was still a small but 
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substantial proportion of participants that indicated a limited number of responses were 
utilised (25.51% endorsed ≤3 interventions). Two thirds of respondents indicated that most 
of the interventions listed were undertaken in response to drug use in their setting (except 
segregation/seclusion and urine/blood screening).  This included therapeutic approaches 
such as health education and motivational interventions as well as “policing” interventions 
such as searching of property and suspension of leave from hospital.   
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Table 3: Number (%) of practitioners that reported the intervention was available in their setting  
Type of interventions 
Total sample 
N = 98 
Further assessment 65 (66.33) 
Harm reduction and health education 
advice 
66 (67.35) 
Motivational work to support the 
person in choices about their substance 
misuse 
60 (61.22) 
Suspending leave from the ward 62 (63.27) 
Searching person’s property and 
person 
69 (70.41) 
Banning certain visitors 60 (61.22) 
Seclusion or segregation 32 (35.65) 
 14 
Detention under mental health act 30 (30.61) 
Urine and/or blood tests to detect NPS 50 (51.02) 
 
 15 
 Free Text Concerns related to NPS 
When invited to share their concerns in a free text box in the survey about NPS, 68 
(69.39%) practitioners provided comments. Some practitioners made several points 
and to facilitate analysis these were separated into individual points (N=111).  
The main concerns expressed (41% of the comments) related to their perception of 
the impact or consequences of NPS.  These included comments regarding deleterious 
impact on mental health, as well as physical health:  
“Increased Aggression and deterioration of physical health” (mental health nurse, general 
adult inpatient) 
“deterioration of mental health, often resulting in aggressive presentation, loss of leave, 
unable to take part in therapeutic day, lack of progress in rehabilitation process” (mental 
health nurse, adult recovery inpatient unit) 
 
 “cardiac and respiratory arrest” (mental health nurse, general adult inpatient) 
 
“….we have had 2 service users have a very extremes physical reaction to Spice, requiring 
emergency treatment..” (mental health nurse, general adult inpatient) 
 
“That it will kill someone whilst in hospital” (mental health nurse nurse, general adult 
inpatient) 
 
The comments also mentioned concerns regarding NPS use leading to behavioral 
disturbances including violence and aggression and impact on safety for the whole ward: 
“We have no standard way to treat those who have become highly agitated/ aggressive. We 
need to keeping everyone safe.” (mental health nurse, general adult inpatient, Europe) 
 
“responsible for causing violence and aggression.” (healthcare assistant, general adult 
inpatient, Europe) 
 
“…severe affect on the mental state of service users, creating a more dangerous environment 
and much higher levels of violence and aggression” (mental health nurse, general adult 
inpatient, Europe) 
 
Some of the comments related to concerns that not enough was known about NPS as well as 
the unpredictability of the effects on indviduals  
 16 
“The fact that we are currently playing "catch up" and are unaware of the extent of dangers 
posed” (Psychologist, forensic inpatient setting, Europe)  
 
“Unpredictability of the effects of individual substances as well as the unpredictable nature of 
how the substances may interact with other substances the person may be taking and the 
large discrepancies in the effects on different people” (psychologist, Forensic inpatient 
setting, Europe) 
 
In additon there were a few comments which referred to access to NPS both whilst off the 
unit (for example, during leave) as well as awareness that NPS were distributed to inpatients 
by other patients:  
 
Freely available with unknown long-term effects. Little information regarding safety and 
health effects for patients to access. (mental health nurse, general adult inpatient, Europe) 
 
“The ease of access that service users have when on leave. Recognising NPS if they were 
brought in to the ward/found in patient belongings” (mental health nurse, general adult 
inpatient, Europe) 
 
“…users are bring in NPS and distributing it to other service users..” (other Allied health 
professional, general adult inpatient, Europe) 
 
“….inpatients being able to bring it to other service users/patients.” (unknown background of 
respondent) 
 
 
 
There were some concerns that NPS are difficult to detect in routine blood or urine tests 
available to them:   
“A lot of NPS are not detected in our urine drug screening” (registered nurse, general adult inpatient, 
Australia) 
 
“Difficult to detect”  (mental health nurse, child and adolescent inpatient unit, Europe) 
 
“Unable to identify in urine drug tests available” (mental health nurse, general adult inpatient, Europe) 
 
 
 
Free Text about Training and Support Needs 
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A total of 46 (46.94%) of the participants commented on their training and support 
needs, resulting in a total of 72 individual points.  This included  training on spotting 
the signs of NPS, and their effects on physical and mental health.  
“recognition of what the substances look like and the impact on physical and mental health (mental 
health nurse, general adult inpatient, Europe) 
 
“Training on what it is, how it formulated, effects on mental health, contra indications of use with 
psychiatric drugs. Physical effects on patient” (mental health nurse, recovery unit, Europe) 
 
“We need to know what they are, how to look out for them( as they change so fast, we cannot always 
recognise legal highs when we see them!) , tools for educating service users in the impact of legal 
highs” (mental health nurse, general adult inpatient, Europe) 
 
“I do not have access to any training or support around NPS from my trust. I would like to have a better 
understanding of physical and psychological impacts of NPS. I would like am evidence based approach 
to work from with regard to the short term management of people using NPS in a psychiatric setting. I 
think that Doctors need further training with regard to this area as they often have to make prescribing 
decisions” (mental health nurse, general adult inpatient, Europe) 
 
Some stated that there was some substance use provided where they worked, but 
others highlighted a lack of training locally. Three comments made suggestions 
relating to format of such training, and suggested email briefing notes or informal 
discussions, as opposed to more traditional forms of training i.e. classroom based.   
 
Discussion 
There is emerging evidence that novel psychoactive substance use (NPS) is becoming 
increasingly common in vulnerable populations including the homeless, offenders in 
prison and those who use mental health services (European Monitoring Centre for 
Drugs and Drug Addiction, 2017).  There is a lack of evidence regarding the scale and 
impact of this phenomenon, and a recent systematic review into NPS and impact of 
mental health revealed limited epidemiological research (Gray et al, 2016).  However 
the review reported on several single case studies that revealed some serious and 
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potentially life-threatening consequences of NPS use by people in mental health 
units. 
Substance use is common in people who use inpatient services and it has been 
established that ward staff lack skills and confidence to address substance use as part 
of a person’s plan of care.  With the rise in concern about the use of the “newer” 
psychoactive drugs, an exploratory survey was devised to scope the current 
perceptions and concerns of mental health staff who currently work in inpatient 
mental health settings.  A total of 98 people out of 118 who started the survey were 
included in the analysis. They were mostly from Europe but there was a small 
proportion who worked in “other regions” including Australasia, Asia and Middle East. 
 
The main findings were that the participants perceived that NPS use is common 
amongst people who get admitted to mental health inpatient facilities. In addition, 
there was consensus from the participants that they perceived that people were able 
to access and use NPS during their admission.  This is unsurprising considering that 
access and use of substance use in inpatient mental health services is well-reported in 
the literature.   
 
In terms of how they reported they responded to the use of NPS, the most common 
response checked on the survey in Europe was the searching of property and 
suspension of leave, and in other regions it was the use of blood and urine testing.  
However, encouragingly, around 2/3 of respondents indicated that they implemented 
a range of treatment responses to NPS use such as motivational interviewing and 
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harm reduction/health educational approaches. Half responded that that they had 
access to specific NPS urine and/or blood screening tests. 
 
A third of respondents reported that NPS specifically featured in their local 
organisation substance use policy.  There was also a reported training and education 
need.  Whilst some respondants reported that they had access to training and 
information, many comments related to having a lack of substance use training.  In 
terms of content, most respondents wanted access to more information about NPS 
including what they looked like, how they worked, and the potential impact on 
mental state.  In terms of the format, it was suggested that email briefings and 
opportunities to discuss with peers would be prefered to formal classroom-based 
training.  They also commented on a lack of information aimed at service users about 
NPS.  A possible solution to this would be to create an online toolkit that offered 
knowledge of NPS, the types, what they look like, as well as the effects and impact on 
on mental health.  There is also a need to create some resources on NPS aimed at 
people who have mental health problems themselves.   
 
The findings suggests that NPS are being used by people with mental health problems 
and that staff are observing negative consequences of that use in mental health 
inpatient settings (including deterioration of mental state and violence).  Of concern 
was how few respondents were sure that NPS featured in their local policy.  The most 
likely response to NPS use was a search of property and suspension of leave. This 
suggests that the role of the mental health professional in inpatient settings with 
regards to substance use continues to be one of “policing” of substance use rather 
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than the use of therapeutic approaches such as motivational interviewing and health 
education.   
 
Inpatient mental health admissions can be seen as a “golden opportunity” to 
undertake some key psychosocial work on substance use, the impact on mental 
health and develop a plan to address this post-discharge.  Pilot studies that utilize 
brief motivational interviewing in inpatient settings have shown some promise in 
reducing substance use and increasing engagement with substance use treatment 
settings but these have mainly focused on cannabis and alcohol (Bagoien et al., 2013, 
Baker et al., 2002, Graham et al., 2016) .   
 
Given that such a significant proportion of people in mental health units have 
substance use problems, it is imperative that staff have the right skills and knowledge 
to undertake this work, especially when faced with new and less well-understood NPS 
drugs.  Their work should be guided by national and local (up to date) policies and 
protocols.  This attention to “dual diagnosis” requires leadership by a clinical expert 
such as an advanced practitioner or consultant nurse.  As patterns of substance use 
change, there needs to be a clear mechanism by which to feed this information (in a 
usable format) to front-line practitioners.  Mental health staff who responded to the 
survey are clearly anxious about NPS, and some of this may be because of lack of 
knowledge.   
 
However, the survey was exploratory in nature and designed as an initial scope into 
perceptions of inpatient staff and so the findings should be taken with some caution.  
 21 
Firstly, the method limites the generalisability as it was a convenience sample drawn 
from social media posts and via local email networks.  It is possible that only people 
who had concerns about NPS chose to respond to the survey invitation and therefore 
may not represent the views of the mental health inpatient workforce.  It was also 
limited by the method of distribution, possibly excluding people who are not able to 
access emails, computers or smart mobile devices.  It would be useful to replicate this 
with an appropriately calculated sample size with a more representative sample of 
inpatient mental health staff.  The findings that relate to the estimate of use of NPS 
must also be taken with some caution as this is not independently verified data.  A 
more robust way of estimating prevalence of NPS would be through a robustly 
conducted prevalence study using a representative sample and verifying self-report 
with objective evidence such as urine or blood tests.   
 
In conclusion, the scoping survey revealed that the respondants had concerns about 
the use of NPS in terms of both mental health and physical health effects.  Not 
everyone was aware of whether their local organisation substance use policy included 
procedures related to NPS use.  In the free text, people expressed their need for more 
specific information on NPS, as well as educational resources for others.  It was 
encouraging to see that as well as the “policing” interventions such as searching for 
drugs, that the respondants also reported therapetic approaches were also used 
including assessment, motivational approaches and harm reduction/ health 
education.   
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In order to provide front line staff with the information they need to inform good 
clinical practice, we need to understand much more about NPS and mental health.  As 
there is currently no reliable prevalence data on the levels and types of use of NPS in 
this population, there is a clear need to undertake such an exercise.  In addition, there 
is a need to develop inpatient mental health staff skills in working effectively with 
substance use in general, and NPS in particular. Appropriate health education tools 
should be developed to support this work.  
 
This study was part-funded by NIHR Collaboration for Applied Health Research – 
Yorkshire and Humber. 
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